5,7-dihydroxytryptamine has been researched along with 4-(2'-methoxyphenyl)-1-(2'-(n-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hull, EM; Lorrain, DS; Matuszewich, L | 1 |
1 other study(ies) available for 5,7-dihydroxytryptamine and 4-(2'-methoxyphenyl)-1-(2'-(n-(2''-pyridinyl)-4-iodobenzamido)ethyl)piperazine
| Article | Year |
|---|---|
8-OH-DPAT influences extracellular levels of serotonin and dopamine in the medial preoptic area of male rats.
Topics: 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Aminopyridines; Animals; Carrier Proteins; Dopamine; Extracellular Space; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microdialysis; Microinjections; Nerve Tissue Proteins; Piperazines; Preoptic Area; Rats; Rats, Inbred Strains; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Sexual Behavior, Animal | 1998 |